Pharma Isn't Broken — Access Is

ixlayer x Sanofi Ventures @ HLTH 2025 Patients don't suffer because we lack medical innovation — they suffer because it takes too long to access it.

🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it.

The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers:

• How digital platforms reduce barriers to treatment
• How AI is fueling proactive, personalized care
• Why strategic capital accelerates patient-impact innovation

Featuring: Pouria Sanae — Co-Founder & CEO, ixlayer Cris De Luca — Sanofi Ventures ⏱️

Timestamps

00:00 — Live at HLTH: Rethinking the pharma-patient connection

02:18 — Why patient access is the real bottleneck

04:20 — Sanofi Ventures: inside the strategic innovation model

06:45 — The truth about time-to-treatment in America

08:40 — The evolution of ixlayer & diagnostics infrastructure

10:30 — Can big pharma really go patient-first?

12:00 — Evidence, outcomes & trust in AI + health tech

Listen & Subscribe Never miss an episode where we challenge the status quo in healthcare and spotlight the innovators building what's next.

Healing Healthcare™ starts with bold ideas — and the courage to build them.

#healthcareinnovation #digitalhealth #patientaccess #boombostichealth #aiinhealthcare #healthtech #pharmainnovation #futureofhealthcare #hlth2025 #hlthusa #PrecisionMedicine